Serum Neurofilament Light as a Neuropsychiatric Disorder Screening Test in Psychiatric Emergency Settings
sNfL is a promising biomarker for rapid differentiation in PEDs between primary psychiatric disorders and psychiatric conditions of general medical or neurological origins, potentially improving diagnostic accuracy and speed. Future research is needed with more diverse, prospective cohorts with a wider range of diseases to replicate the clinical utility of sNfL.
Authors
- Sherri Lee Jones (ORCID: https://orcid.org/0000-0003-0511-7198)
- Hamza Zarglayoun
- Victoria Light (ORCID: https://orcid.org/0009-0000-0621-7970)
- Charlotte Elisabeth Teunissen (ORCID: https://orcid.org/0000-0002-4061-0837)
- Simon Ducharme (ORCID: https://orcid.org/0000-0002-7309-1113)
- Katerine Rousseau
Institutions
- Montreal Neurological Institute and Hospital (CA)
- Douglas Mental Health University Institute (CA)
- Amsterdam Neuroscience (NL)
- Institut Universitaire en Santé Mentale de Québec (CA)
- Imaging Center (US)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Journal of Neuropsychiatry
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1176/appi.neuropsych.20240228
- Citations
- 1
- Primary Topic
- Psychosomatic Disorders and Their Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.47